Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Peripheral-Type Benzodiazepine Receptor (TSPO) Peptid

TSPO Reaktivität: Human Wirt: Synthetic BP, BI
Produktnummer ABIN5686068
  • Target Alle TSPO Produkte
    TSPO (Peripheral-Type Benzodiazepine Receptor (TSPO))
    Spezies
    Human
    Quelle
    • 6
    Synthetic
    Applikation
    Blocking Peptide (BP), BioImaging (BI)
    Produktmerkmale
    TSPO peptide corresponds to 14 amino acids of TSPO.
  • Applikationshinweise
    TSPO Peptide is used for blocking the activity of TSPO antibody . The TSPO antibody ships at 0.5 mg/mL and the TSPO Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    TSPO peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    TSPO (Peripheral-Type Benzodiazepine Receptor (TSPO))
    Gen-ID
    706
    NCBI Accession
    NP_000705
    OMIM
    74275350
    UniProt
    P30536
Sie sind hier:
Kundenservice